The Unexplored Role of Connexin Hemichannels in Promoting Facioscapulohumeral Muscular Dystrophy Progression
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26010373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Macarena Díaz-Ubilla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7550000, Chile. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Connexins. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondecyt, ANID Fondecyt Regular.
Abstract (Originalsprache)
DUX4 is typically a repressed transcription factor, but its aberrant activation in Facioscapulohumeral Muscular Dystrophy (FSHD) leads to cell death by disrupting muscle homeostasis. This disruption affects crucial processes such as myogenesis, sarcolemma integrity, gene regulation, oxidative stress, immune response, and many other biological pathways. Notably, these disrupted processes have been associated, in other pathological contexts, with the presence of connexin (Cx) hemichannels—transmembrane structures that mediate communication between the intracellular and extracellular environments. Thus, hemichannels have been implicated in skeletal muscle atrophy, as observed in human biopsies and animal models of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Dysferlinopathies, suggesting a potentially shared mechanism of muscle atrophy that has not yet been explored in FSHD. Despite various therapeutic strategies proposed to manage FSHD, no treatment or cure is currently available. This review summarizes the current understanding of the mechanisms underlying FSHD progression, with a focus on hormones, inflammation, reactive oxygen species (ROS), and mitochondrial function. Additionally, it explores the potential of targeting hemichannels as a therapeutic strategy to slow disease progression by preventing the spread of pathogenic factors between muscle cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7550000, Chile.
- Programa de Comunicación Celular en Cáncer, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7550000, Chile.
ORCID-Profile: Macarena Díaz-Ubilla, Mauricio A Retamal
Förderung
- Fondecyt
- ANID Fondecyt Regular
Zitieren
APA
Díaz-Ubilla, M., & Retamal, M. A. (2025). The Unexplored Role of Connexin Hemichannels in Promoting Facioscapulohumeral Muscular Dystrophy Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010373
Vancouver
Díaz-Ubilla M, Retamal MA. The Unexplored Role of Connexin Hemichannels in Promoting Facioscapulohumeral Muscular Dystrophy Progression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26010373
BibTeX
@article{DazUbilla2025,
author = {Díaz-Ubilla, Macarena and Retamal, Mauricio A},
title = {The Unexplored Role of Connexin Hemichannels in Promoting Facioscapulohumeral Muscular Dystrophy Progression},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26010373}
}
EUVIMED